In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-21 of 21 for your search:
Drug:  metformin hydrochloride
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 74
Sponsor: NCI, Other
Protocol IDs: MA32, U10CA077202, CAN-NCIC-MA.32, CDR0000669788, NCIC-MA.32, NCT01101438

2.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: AAAD6525, NCT00930579

3.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 to 75
Sponsor: Other
Protocol IDs: CDR0000681691, PACT-17, 2010-020979-23, SRSI-PACT-17, EUDRACT-2010-020979-23, EU-21052, NCT01167738

4.

Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 80
Sponsor: Other
Protocol IDs: AMCmedonc10/003, NCT01210911

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SAKK 08/09, SWS-SAKK-08/09, CDR0000688789, EU-21084, NCT01243385

6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: EP-TSC-647, NCT01266486

7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 35 to 80
Sponsor: NCI
Protocol IDs: NCI-2011-01744, UCI 10-31, 2010-7705, UCI09-13-01, P30CA062203, N01CN35160, NCT01312467

8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-03451, MAY10-15-03, MAYO-MAY10-15-03, CDR0000698069, NCT01447927

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 19 and over
Sponsor: NCI
Protocol IDs: NCI-2012-00243, CDR0000712087, UARIZ-UAZ10-16-01, 11-0211-04, UAZ10-16-01, N01CN35158, P30CA023074, NCT01433913

10.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2011-1239, NCI-2012-01164, NCT01627067

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 134190, NCT01632020

12.

Phase: Phase II
Type: Treatment
Status: Enrolling by invitation
Age: Over 18
Sponsor: Other
Protocol IDs: feMMe, NCT01686126

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis
Status: Closed
Age: 45 to 65
Sponsor: Other
Protocol IDs: 138647, NCT01877564

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: NP 96/2010, NCT01971034

15.

Phase: Phase I
Type: Treatment
Status: Completed
Age: Over 18
Sponsor: Other, Pharmaceutical / Industry
Protocol IDs: CAN-LRCC-UWOREB13877, UWOREB13877, WYETH-CAN-LRCC-UWOREB13877, NCT00659568

16.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2008-0284, NCT00933309

17.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 to 79
Sponsor: Other
Protocol IDs: Metformin Anticancer + Chemo, NCT01442870

18.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: METFORMIN, NCT00897884

19.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 80
Sponsor: Other
Protocol IDs: 2009-0927, NCT01205672

20.

Phase: No phase specified
Type: Treatment
Status: Closed
Age: Not specified
Sponsor: Other
Protocol IDs: 10-244, NCT01215032

21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology, Tissue collection/Repository
Status: Closed
Age: 18 to 74
Sponsor: NCI, Other
Protocol IDs: NSABP MA.32.F, NSABP-NCIC-CTG-MA.32.F, NCT01286233
New Search